Human brain changes after first psilocybin use

Read full text
Authors: T Lyons, M Spriggs, L Kerkelä, FE Rosas, L Roseman, P. Mediano, C Timmermann, L Oestreich, BA Pagni, RJ Zeifman, A Hampshire, W Trender
+11 more HM Douglass, M Girn, K Godfrey, H Kettner, F Sharif, L Espasiano, A Gazzaley, MB Wall, D Erritzoe, DJ NUTT, RL Carhart-Harris
Cited by: 5
References: 97

Abstract

Psychedelics have robust effects on acute brain function and long-term behavior but whether they also cause enduring functional and anatomical brain changes is largely unknown. In an exploratory, placebo-controlled, within-subjects, electroencephalography (EEG), and magnetic resonance imaging (MRI) study in 28 healthy, entirely psychedelic-naive participants, anatomical and functional brain changes are detected from one-hour to one-month after a single high-dose (25 mg) of psilocybin. Increases in cognitive flexibility, psychological insight, and well-being are seen at one-month. Diffusion tensor imaging (DTI) done before and one-month after 25mg psilocybin reveals decreased axial diffusivity bilaterally in prefrontal-subcortical tracts that correlate with decreases in brain network modularity (fMRI) over the same month. Enduring functional brain changes are largely absent, but network modularity change (numerical decrease) negatively correlates with well-being change (significant increase), in line with previous findings in depression. Increased cortical signal entropy (EEG) at 1- and 2-hours post-dosing predicts improved psychological well-being at one-month. Next-day psychological insight mediates the entropy to well-being relationship. All effects are exclusive to 25mg psilocybin; no effects occur with a 1mg psilocybin placebo.

Fields of Study & Subjects

Psychedelics and Drug Studies Pain Management and Placebo Effect Forensic Toxicology and Drug Analysis

Publication details

Journal / source
Spiral (Imperial College London)
Publisher
Springer Science and Business Media LLC
Volume
17
Issue
1
Publication date
1 April 2026